Stokes Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
43,686
+1,977
+5% +$461K 2.38% 13
2026
Q1
$10.2M Buy
41,709
+754
+2% +$176K 2.29% 12
2025
Q4
$8.48M Buy
40,955
+959
+2% +$190K 1.94% 19
2025
Q3
$7.42M Buy
39,996
+2,261
+6% +$387K 1.73% 27
2025
Q2
$5.76M Sell
37,735
-1,732
-4% -$266K 1.41% 36
2025
Q1
$6.55M Buy
39,467
+294
+0.8% +$46K 1.66% 28
2024
Q4
$5.67M Sell
39,173
-529
-1% -$82K 1.46% 35
2024
Q3
$6.43M Sell
39,702
-1,323
-3% -$211K 1.65% 33
2024
Q2
$6M Sell
41,025
-4,527
-10% -$673K 1.67% 32
2024
Q1
$7.21M Buy
45,552
+3,590
+9% +$571K 2.1% 20
2023
Q4
$6.58M Sell
41,962
-1,570
-4% -$241K 2.08% 20
2023
Q3
$6.78M Sell
43,532
-1,555
-3% -$257K 2.37% 10
2023
Q2
$7.46M Sell
45,087
-798
-2% -$129K 2.51% 7
2023
Q1
$7.11M Buy
45,885
+489
+1% +$79K 2.42% 9
2022
Q4
$8.02M Buy
45,396
+1,294
+3% +$223K 2.76% 5
2022
Q3
$7.21M Sell
44,102
-320
-0.7% -$54.1K 2.68% 5
2022
Q2
$7.88M Buy
44,422
+458
+1% +$81.6K 2.76% 3
2022
Q1
$7.79M Buy
43,964
+2,389
+6% +$406K 2.27% 7
2021
Q4
$7.11M Buy
41,575
+1,458
+4% +$239K 2.12% 16
2021
Q3
$6.48M Buy
40,117
+949
+2% +$162K 2.09% 15
2021
Q2
$6.45M Buy
39,168
+7,453
+23% +$1.23M 2.12% 13
2021
Q1
$5.21M Buy
31,715
+1,375
+5% +$222K 2.14% 12
2020
Q4
$4.78M Buy
30,340
+1,383
+5% +$204K 2.08% 15
2020
Q3
$4.31M Sell
28,957
-3,473
-11% -$514K 2.07% 15
2020
Q2
$4.56M Buy
32,430
+880
+3% +$128K 2.41% 8
2020
Q1
$4.14M Buy
31,550
+892
+3% +$127K 2.48% 7
2019
Q4
$4.47M Buy
30,658
+4,270
+16% +$579K 2.26% 9
2019
Q3
$3.41M Buy
26,388
+3,635
+16% +$479K 1.85% 21
2019
Q2
$3.17M Buy
22,753
+525
+2% +$72.7K 1.8% 18
2019
Q1
$3.11M Buy
22,228
+1,145
+5% +$153K 1.87% 13
2018
Q4
$2.72M Buy
21,083
+1,480
+8% +$206K 1.88% 13
2018
Q3
$2.71M Buy
19,603
+735
+4% +$97.7K 1.66% 18
2018
Q2
$2.29M Buy
18,868
+1,930
+11% +$241K 1.5% 21
2018
Q1
$2.17M Buy
16,938
+109
+0.6% +$14.7K 1.42% 25
2017
Q4
$2.35M Buy
+16,829
New +$2.34M 1.59% 15

Other funds holding JNJ

Stokes Capital Advisors's JNJ Position: Q2 2026 in Review

Stokes Capital Advisors increased its Johnson & Johnson (JNJ) stake by 4.7% in Q2 2026, buying an estimated $461K and bringing the position to 43,686 shares worth $11.1M. The position accounts for 2.38% of the portfolio, ranked #13.

Stokes Capital Advisors first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stokes Capital Advisors held 43,686 shares of Johnson & Johnson worth $11.1M as of Q2 2026.
  • Stokes Capital Advisors bought 1,977 Johnson & Johnson shares in Q2 2026, an estimated $461K.
  • Johnson & Johnson made up 2.38% of Stokes Capital Advisors's portfolio in Q2 2026, its #13 holding.
  • Stokes Capital Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stokes Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.